GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (XTER:1SXP) » Definitions » FCF Yield %

Schott Pharma AG KGaA (XTER:1SXP) FCF Yield % : 2.18 (As of Jan. 18, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Schott Pharma AG KGaA's Trailing 12-Month Free Cash Flow is €80.0 Mil, and Market Cap is €3,675.0 Mil. Therefore, Schott Pharma AG KGaA's FCF Yield % for today is 2.18%.

The historical rank and industry rank for Schott Pharma AG KGaA's FCF Yield % or its related term are showing as below:

XTER:1SXP' s FCF Yield % Range Over the Past 10 Years
Min: -0.09   Med: 0.46   Max: 2.2
Current: 2.18


During the past 5 years, the highest FCF Yield % of Schott Pharma AG KGaA was 2.20%. The lowest was -0.09%. And the median was 0.46%.

XTER:1SXP's FCF Yield % is ranked better than
73.23% of 863 companies
in the Medical Devices & Instruments industry
Industry Median: -2.29 vs XTER:1SXP: 2.18

Schott Pharma AG KGaA's FCF Margin % for the quarter that ended in Sep. 2024 was 4.76%.


Schott Pharma AG KGaA FCF Yield % Historical Data

The historical data trend for Schott Pharma AG KGaA's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA FCF Yield % Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
FCF Yield %
- - - 0.13 1.73

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.96 2.97 -0.19 2.95 0.98

Competitive Comparison of Schott Pharma AG KGaA's FCF Yield %

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Schott Pharma AG KGaA's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's FCF Yield % falls into.



Schott Pharma AG KGaA FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Schott Pharma AG KGaA's FCF Yield % for the fiscal year that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=80.03 / 4617.8559
=1.73%

Schott Pharma AG KGaA's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=11.29 * 4 / 4617.8559
=0.98%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Schott Pharma AG KGaA FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Schott Pharma AG KGaA FCF Yield % Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Schott Pharma AG KGaA Business Description

Traded in Other Exchanges
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.
Executives
Dr. Jens Schulte Supervisory Board
Andreas Reisse Board of Directors
Ann-kristin Erkens Supervisory Board
Dr. Almuth Steinkühler Board of Directors
Dr. Wolfgang Wienand Supervisory Board
Peter Goldschmidt Supervisory Board

Schott Pharma AG KGaA Headlines

No Headlines